Sign in
4

Changes in Ownership

LISATA THERAPEUTICS, INC. Filed Acc 0001879231-24-000002

EVP, R&D and CMO gave up 5,880 shares (to pay taxes)

  • EVP, R&D and CMO acquired 27,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Buck Kristen K · EVP, R&D and CMO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-09 Grant or award : show line 1 in the form +27,000 59,915 D
2024-01-09 Shares withheld for taxes : show line 2 in the form −3,221 $3.08 $9,921 56,694 D
2024-01-09 Shares withheld for taxes : show line 3 in the form −2,147 $3.08 $6,613 54,547 D
2024-01-10 Shares withheld for taxes : show line 4 in the form −512 $3.00 $1,536 54,035 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-09 Grant or award : show line 5 in the form Stock Option (Right to Buy) +14,000 14,000 D
Loading xslF345X05/wk-form4_1705007506.xml…